AU2002239491A1 - Methods for the treatment of cancer and other diseases and methods of developing the same - Google Patents
Methods for the treatment of cancer and other diseases and methods of developing the sameInfo
- Publication number
- AU2002239491A1 AU2002239491A1 AU2002239491A AU3949102A AU2002239491A1 AU 2002239491 A1 AU2002239491 A1 AU 2002239491A1 AU 2002239491 A AU2002239491 A AU 2002239491A AU 3949102 A AU3949102 A AU 3949102A AU 2002239491 A1 AU2002239491 A1 AU 2002239491A1
- Authority
- AU
- Australia
- Prior art keywords
- methods
- cancer
- diseases
- developing
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/18—Testing for antimicrobial activity of a material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/20—Screening for compounds of potential therapeutic value cell-free systems
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Toxicology (AREA)
- Genetics & Genomics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24671700P | 2000-11-09 | 2000-11-09 | |
| US60/246,717 | 2000-11-09 | ||
| PCT/US2001/046194 WO2002040702A2 (en) | 2000-11-09 | 2001-11-08 | Methods for the treatment of cancer and other diseases and methods of developing the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2002239491A1 true AU2002239491A1 (en) | 2002-05-27 |
Family
ID=22931903
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002239491A Abandoned AU2002239491A1 (en) | 2000-11-09 | 2001-11-08 | Methods for the treatment of cancer and other diseases and methods of developing the same |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2002239491A1 (en) |
| WO (1) | WO2002040702A2 (en) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090062909A1 (en) | 2005-07-15 | 2009-03-05 | Micell Technologies, Inc. | Stent with polymer coating containing amorphous rapamycin |
| AU2006270221B2 (en) | 2005-07-15 | 2012-01-19 | Micell Technologies, Inc. | Polymer coatings containing drug powder of controlled morphology |
| CA2650590C (en) | 2006-04-26 | 2018-04-03 | Micell Technologies, Inc. | Coatings containing multiple drugs |
| CA2667228C (en) | 2006-10-23 | 2015-07-14 | Micell Technologies, Inc. | Holder for electrically charging a substrate during coating |
| JP5603598B2 (en) | 2007-01-08 | 2014-10-08 | ミセル テクノロジーズ、インコーポレイテッド | Stent with biodegradable layer |
| US11426494B2 (en) | 2007-01-08 | 2022-08-30 | MT Acquisition Holdings LLC | Stents having biodegradable layers |
| JP2010527746A (en) | 2007-05-25 | 2010-08-19 | ミセル テクノロジーズ、インコーポレイテッド | Polymer film for medical device coating |
| SG192523A1 (en) | 2008-04-17 | 2013-08-30 | Micell Technologies Inc | Stents having bioabsorbable layers |
| WO2011009096A1 (en) | 2009-07-16 | 2011-01-20 | Micell Technologies, Inc. | Drug delivery medical device |
| EP2313122B1 (en) | 2008-07-17 | 2019-03-06 | Micell Technologies, Inc. | Drug delivery medical device |
| US8834913B2 (en) | 2008-12-26 | 2014-09-16 | Battelle Memorial Institute | Medical implants and methods of making medical implants |
| US20100239635A1 (en) | 2009-03-23 | 2010-09-23 | Micell Technologies, Inc. | Drug delivery medical device |
| CN102481195B (en) | 2009-04-01 | 2015-03-25 | 米歇尔技术公司 | coated stent |
| EP3366326A1 (en) | 2009-04-17 | 2018-08-29 | Micell Technologies, Inc. | Stents having controlled elution |
| US11369498B2 (en) | 2010-02-02 | 2022-06-28 | MT Acquisition Holdings LLC | Stent and stent delivery system with improved deliverability |
| US8795762B2 (en) | 2010-03-26 | 2014-08-05 | Battelle Memorial Institute | System and method for enhanced electrostatic deposition and surface coatings |
| BR112012024619A2 (en) * | 2010-03-31 | 2016-05-31 | Diatech Oncology Llc | system and method for evaluating anticancer drug candidate |
| US10232092B2 (en) | 2010-04-22 | 2019-03-19 | Micell Technologies, Inc. | Stents and other devices having extracellular matrix coating |
| EP2593039B1 (en) | 2010-07-16 | 2022-11-30 | Micell Technologies, Inc. | Drug delivery medical device |
| WO2012166819A1 (en) | 2011-05-31 | 2012-12-06 | Micell Technologies, Inc. | System and process for formation of a time-released, drug-eluting transferable coating |
| CA2841360A1 (en) | 2011-07-15 | 2013-01-24 | Micell Technologies, Inc. | Drug delivery medical device |
| US10188772B2 (en) | 2011-10-18 | 2019-01-29 | Micell Technologies, Inc. | Drug delivery medical device |
| US9476871B2 (en) * | 2012-05-02 | 2016-10-25 | Diatech Oncology Llc | System and method for automated determination of the relative effectiveness of anti-cancer drug candidates |
| JP2015517662A (en) * | 2012-05-15 | 2015-06-22 | ダイアテツク・オンコロジー | Tumor cell isolation / purification method and method of use thereof |
| KR20150143476A (en) | 2013-03-12 | 2015-12-23 | 미셀 테크놀로지즈, 인코포레이티드 | Bioabsorbable biomedical implants |
| JP2016519965A (en) | 2013-05-15 | 2016-07-11 | マイセル・テクノロジーズ,インコーポレイテッド | Bioabsorbable biomedical implant |
| WO2015171848A2 (en) * | 2014-05-08 | 2015-11-12 | Diatech Oncology, Llc | Synergism and antagonism between multiple anti-cancer agents determined by mick assay |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994017177A1 (en) * | 1993-01-27 | 1994-08-04 | Batle Luminetrics Enterprises, Inc. | Methods and kits for determining effects of anti-cancer agents on cancer cells |
| US6077684A (en) * | 1996-11-14 | 2000-06-20 | Vanderbilt University | Automated assay for measuring apoptosis in cell culture |
-
2001
- 2001-11-08 AU AU2002239491A patent/AU2002239491A1/en not_active Abandoned
- 2001-11-08 WO PCT/US2001/046194 patent/WO2002040702A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002040702A2 (en) | 2002-05-23 |
| WO2002040702A3 (en) | 2004-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002239491A1 (en) | Methods for the treatment of cancer and other diseases and methods of developing the same | |
| AU2001268259A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
| AU2001269766A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
| AU2002332430A1 (en) | Methods of treating neuropilin-mediated diseases | |
| AU2002251841A1 (en) | Compositions and methods for the therapy and diagnosis of pancreatic cancer | |
| AU2072201A (en) | Agents and methods for the treatment of proliferative diseases | |
| AU2001261007A1 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
| AU2495200A (en) | Compositions and methods for the treatment of tumor | |
| AU2003200731A1 (en) | Compositions and methods for the treatment of tumor | |
| AU2003200740A1 (en) | Compositions and methods for the treatment of tumor | |
| AU2003200722A1 (en) | Compositions and methods for the treatment of tumor | |
| AU2001280982A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
| AU2002246519A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
| AU2002303219A1 (en) | Compositions and methods for the therapy and diagnosis of cancer | |
| AU2002210385A1 (en) | Furazanyl-triazole derivates for the treatment of diseases | |
| AU2001243349A1 (en) | Methods for the diagnosis and treatment of breast cancer | |
| AU2001259062A1 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
| AU2001290518A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
| AU2001273149A1 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
| AU2001271284A1 (en) | Compositions and methods for the therapy and diagnosis of pancreatic cancer | |
| AU2001273127A1 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
| AU2001296224A1 (en) | Compositions and methods for the therapy and diagnosis of pancreatic cancer | |
| AU2001266790A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
| AU2001258575A1 (en) | Treatment of cancer and neurological diseases | |
| AU2002366195A1 (en) | Use of bisindolmaleimide and gemcitabine for the treatment of cancer |